NYSE:MDC

M.D.C. Price Target, Predictions & Analyst Ratings

$50.17

-0.05 (-0.10 %)

(As of 10/27/2021 12:00 AM ET)

Add

Compare

Today's Range: $50.12
▼
$52.00
50-Day Range: $46.29
▼
$53.14
52-Week Range: $38.02
▼
$63.86

Volume: 452,126 shs
Average Volume: 525,403 shs
Market Capitalization: $3.54 billion

P/E Ratio: 7.14
Dividend Yield: 3.19%
Beta: 1.43

M.D.C. (NYSE:MDC) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analyst Rating Consensus

Hold
Based on 4 Analyst Ratings

Analyst Price Target Consensus

$68.25
36.04% Upside

High PT	$79.00
Average PT	$68.25
Low PT	$63.00

Type	Current 10/27/20 to 10/27/21	1 Month Ago 9/27/20 to 9/27/21	3 Months Ago 7/29/20 to 7/29/21	1 Year Ago 10/28/19 to 10/27/20
Consensus Rating	Hold	Hold	Buy	Buy
Strong Buy	1 Strong Buy rating(s)	1 Strong Buy rating(s)	1 Strong Buy rating(s)	1 Strong Buy rating(s)
Buy	0 Buy rating(s)	1 Buy rating(s)	2 Buy rating(s)	4 Buy rating(s)
Hold	2 Hold rating(s)	2 Hold rating(s)	2 Hold rating(s)	2 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$68.25	$68.50	$65.40	$48.50
Price Target Upside	36.04% Upside	25.87% Upside	23.10% Upside	28.99% Upside

Get M.D.C. Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for MDC and its competitors with MarketBeat's FREE daily newsletter.

Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

M.D.C. (NYSE:MDC) vs. Its Competitors

Type	M.D.C.	Construction Companies	S&P 500
Consensus Rating Score	2.25	2.53	2.56
Consensus Rating	Hold	Buy	Buy
Price Target Upside	36.04% Upside	37.38% Upside	8.54% Upside
News Sentiment Rating	Neutral News	Neutral News	Neutral News
MarketBeat Community Rating	Outperform Votes 281 56.65% Underperform Votes 215 43.35%	Avg. Outperform Votes 241 64.27% Avg. Underperform Votes 134 35.73%	Avg. Outperform Votes 831 69.48% Avg. Underperform Votes 365 30.52%

M.D.C. (NYSE:MDC) Analyst Ratings History

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
10/14/2021	JPMorgan Chase & Co.		Downgrade	Overweight ➝ Neutral	$66.00	+36.45%
8/19/2021	Raymond James		Lower Price Target	Strong-Buy	$80.00 ➝ $79.00	+56.90%
4/21/2021	Wells Fargo & Company		Initiated Coverage	Equal Weight	$65.00	+10.30%
3/18/2021	Bank of America		Reiterated Rating	Neutral ➝ Underperform	$63.00	+4.65%
3/16/2021	Wolfe Research		Initiated Coverage	Peer Perform
10/26/2020	Zelman & Associates		Downgrade	Buy ➝ Hold
7/29/2020	Evercore ISI	Trey Morrish	Upgrade	In-Line ➝ Outperform	$61.00	+43.39%
4/2/2020	Wedbush		Lower Price Target	Neutral	$40.00 ➝ $29.00	+44.42%
10/31/2019	Cfra		Upgrade	Hold ➝ Buy

(Data available from 10/27/2016 forward. View 10+ years of historical ratings with our analyst ratings screener.)

M.D.C. (NYSE:MDC) Analyst Ratings Frequently Asked Questions

What is M.D.C.'s consensus rating and price target?: According to the issued ratings of 4 analysts in the last year, the consensus rating for M.D.C. stock is Hold based on the current 1 sell rating, 2 hold ratings and 1 strong buy rating for MDC. The average twelve-month price target for M.D.C. is $68.25 with a high price target of $79.00 and a low price target of $63.00. Learn more on MDC's analyst rating history
Do Wall Street analysts like M.D.C. more than its competitors?: Analysts like M.D.C. stock less than the stock of other Construction companies. The consensus rating for M.D.C. is Hold while the average consensus rating for construction companies is Buy. Learn more on how MDC compares to other companies
Do MarketBeat users like M.D.C. more than its competitors?: MarketBeat users like M.D.C. stock less than the stock of other Construction companies. 56.65% of MarketBeat users gave M.D.C. an outperform vote while construction companies recieve an average of 64.27% outperform votes by MarketBeat users.

Is M.D.C. being downgraded by Wall Street analysts?: Over the previous 90 days, M.D.C.'s stock had 1 downgrade by analysts.
Does M.D.C.'s stock price have much upside?: According to analysts, M.D.C.'s stock has a predicted upside of 25.32% based on their 12-month price targets.
What analysts cover M.D.C.?: M.D.C. has been rated by JPMorgan Chase & Co., and Raymond James in the past 90 days.

This page was last updated on 10/27/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

M.D.C. Price Target, Predictions & Analyst Ratings

M.D.C. (NYSE:MDC) Price Target and Consensus Rating